Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Because these tumours tend to be less sensitive than other types of GTD to chemotherapy, the most successful regimen to date has been with EMA/CO or EMA/EP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP191410.RAsOsRXkm9TKOeA0nxhn1zp-L1f6v_9Bu-TXkN8KGSEHc130_assertion description "[Because these tumours tend to be less sensitive than other types of GTD to chemotherapy, the most successful regimen to date has been with EMA/CO or EMA/EP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP191410.RAsOsRXkm9TKOeA0nxhn1zp-L1f6v_9Bu-TXkN8KGSEHc130_provenance.
• NP835431.RAtV8Ts7R3-c14breqf_Ipcjq3Z0Axk5LYABRokZwribU130_assertion description "[Because these tumours tend to be less sensitive than other types of GTD to chemotherapy, the most successful regimen to date has been with EMA/CO or EMA/EP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP835431.RAtV8Ts7R3-c14breqf_Ipcjq3Z0Axk5LYABRokZwribU130_provenance.
• NP578577.RAaudmg7FdZ3r9o2zitEZquJUagMeOiU6kgyHwG1886oc130_assertion description "[Because these tumours tend to be less sensitive than other types of GTD to chemotherapy, the most successful regimen to date has been with EMA/CO or EMA/EP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP578577.RAaudmg7FdZ3r9o2zitEZquJUagMeOiU6kgyHwG1886oc130_provenance.
• NP385991.RAbY9Tw0VY7B2ppGcHom4fjNuQFLuKdhMMUkbafjgf3r0130_assertion description "[Because these tumours tend to be less sensitive than other types of GTD to chemotherapy, the most successful regimen to date has been with EMA/CO or EMA/EP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP385991.RAbY9Tw0VY7B2ppGcHom4fjNuQFLuKdhMMUkbafjgf3r0130_provenance.
• NP420562.RABsrU6bstMa501JxOIYJLEYKdmBqV-xSZ6_VsgnTUBAs130_assertion description "[Because these tumours tend to be less sensitive than other types of GTD to chemotherapy, the most successful regimen to date has been with EMA/CO or EMA/EP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420562.RABsrU6bstMa501JxOIYJLEYKdmBqV-xSZ6_VsgnTUBAs130_provenance.
• NP420560.RAdVV_pivbrhn9Es_eEsNdGdezeKelK5xUiQbErNUQ_Xo130_assertion description "[Because these tumours tend to be less sensitive than other types of GTD to chemotherapy, the most successful regimen to date has been with EMA/CO or EMA/EP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420560.RAdVV_pivbrhn9Es_eEsNdGdezeKelK5xUiQbErNUQ_Xo130_provenance.
• NP420563.RAVVhAG09iNEcdMR_Hqq2DNM54Q9n1wGteGjpliqD7M-8130_assertion description "[Because these tumours tend to be less sensitive than other types of GTD to chemotherapy, the most successful regimen to date has been with EMA/CO or EMA/EP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420563.RAVVhAG09iNEcdMR_Hqq2DNM54Q9n1wGteGjpliqD7M-8130_provenance.
• NP420564.RAdCAjkiNzsQarI44bOYvP6zw6whd_2olQPuWh42diUus130_assertion description "[Because these tumours tend to be less sensitive than other types of GTD to chemotherapy, the most successful regimen to date has been with EMA/CO or EMA/EP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420564.RAdCAjkiNzsQarI44bOYvP6zw6whd_2olQPuWh42diUus130_provenance.
• NP420561.RAnwr811-qBpuU8nNjb2RfwQHtcVqSwbLdGgRZvR6Pgew130_assertion description "[Because these tumours tend to be less sensitive than other types of GTD to chemotherapy, the most successful regimen to date has been with EMA/CO or EMA/EP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420561.RAnwr811-qBpuU8nNjb2RfwQHtcVqSwbLdGgRZvR6Pgew130_provenance.
• NP385999.RAw9RDwHB9ROU0i6Fc3xusmZi0K85-oPtL5UVp4cPWBI8130_assertion description "[Because these tumours tend to be less sensitive than other types of GTD to chemotherapy, the most successful regimen to date has been with EMA/CO or EMA/EP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP385999.RAw9RDwHB9ROU0i6Fc3xusmZi0K85-oPtL5UVp4cPWBI8130_provenance.
• NP386000.RA-krTYTTJNWJQebr1V9bmlWVh4SnQ-sYRo-9HWN0rUAk130_assertion description "[Because these tumours tend to be less sensitive than other types of GTD to chemotherapy, the most successful regimen to date has been with EMA/CO or EMA/EP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP386000.RA-krTYTTJNWJQebr1V9bmlWVh4SnQ-sYRo-9HWN0rUAk130_provenance.
• NP578729.RAymnIRpPwKQr36CkvbvWZkSaMd4KsKf2k5WzfeY-r2xg130_assertion description "[Because these tumours tend to be less sensitive than other types of GTD to chemotherapy, the most successful regimen to date has been with EMA/CO or EMA/EP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP578729.RAymnIRpPwKQr36CkvbvWZkSaMd4KsKf2k5WzfeY-r2xg130_provenance.
• NP578707.RAIMxsrQc7AHMUE40httEMvEF1_sbX97wBlmnr6g2gewc130_assertion description "[Because these tumours tend to be less sensitive than other types of GTD to chemotherapy, the most successful regimen to date has been with EMA/CO or EMA/EP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP578707.RAIMxsrQc7AHMUE40httEMvEF1_sbX97wBlmnr6g2gewc130_provenance.
• NP420565.RA9_oksZg8xRofSlUObgEuGIq5NUFlxVMubnw_y1HE-TQ130_assertion description "[Because these tumours tend to be less sensitive than other types of GTD to chemotherapy, the most successful regimen to date has been with EMA/CO or EMA/EP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420565.RA9_oksZg8xRofSlUObgEuGIq5NUFlxVMubnw_y1HE-TQ130_provenance.